Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
183 | 3 | NOONAN SYNDROME//PTEN//CELL BIOLOGY | 56293 |
559 | 2 | SH2 DOMAIN//BTK//P66SHC | 15006 |
5702 | 1 | CD45//CD45 ISOFORMS//P56LCK | 1616 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CD45 | authKW | 720224 | 9% | 27% | 139 |
2 | CD45 ISOFORMS | authKW | 309030 | 2% | 59% | 27 |
3 | P56LCK | authKW | 212325 | 2% | 33% | 33 |
4 | LCK INHIBITOR | authKW | 181508 | 1% | 85% | 11 |
5 | LCK | authKW | 177014 | 3% | 20% | 45 |
6 | PTPRC | authKW | 60938 | 0% | 63% | 5 |
7 | LPAP | authKW | 58504 | 0% | 100% | 3 |
8 | P50CSK | authKW | 58504 | 0% | 100% | 3 |
9 | PYRIMIDINE BENZIMIDAZOLES | authKW | 58504 | 0% | 100% | 3 |
10 | P59FYN | authKW | 49912 | 0% | 32% | 8 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Immunology | 25187 | 59% | 0% | 951 |
2 | Cell Biology | 1839 | 19% | 0% | 302 |
3 | Biochemistry & Molecular Biology | 1328 | 27% | 0% | 431 |
4 | Hematology | 285 | 5% | 0% | 78 |
5 | Transplantation | 229 | 3% | 0% | 46 |
6 | Genetics & Heredity | 136 | 5% | 0% | 85 |
7 | Medicine, Research & Experimental | 125 | 5% | 0% | 73 |
8 | Pathology | 52 | 2% | 0% | 37 |
9 | Biophysics | 35 | 3% | 0% | 46 |
10 | Chemistry, Medicinal | 34 | 2% | 0% | 35 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PROGRAMME MOL IMMUNOL | 44571 | 0% | 57% | 4 |
2 | HERITAGE MED 6 70 | 39003 | 0% | 100% | 2 |
3 | BIOCHEM SIGNAL TRANSDUCT SECTBLDG 3ROOM 122 | 19501 | 0% | 100% | 1 |
4 | BIOL CELLULAIRE MOLEC CNRS UMR 49 | 19501 | 0% | 100% | 1 |
5 | BIOL PHARMACEUT NEW TECHNOL | 19501 | 0% | 100% | 1 |
6 | CELL GENE THEARPY | 19501 | 0% | 100% | 1 |
7 | CHAIR SEMEIOT METODAL MED | 19501 | 0% | 100% | 1 |
8 | CHAIR SEMIOT METODOL MED | 19501 | 0% | 100% | 1 |
9 | CHU LAUAL | 19501 | 0% | 100% | 1 |
10 | CLIN IMMUNOL ALLERGY CLIN IMMUNOL | 19501 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF IMMUNOLOGY | 24057 | 8% | 1% | 128 |
2 | JOURNAL OF IMMUNOLOGY | 12241 | 11% | 0% | 185 |
3 | INTERNATIONAL IMMUNOLOGY | 9718 | 3% | 1% | 45 |
4 | CELLULAR IMMUNOLOGY | 8570 | 4% | 1% | 59 |
5 | IMMUNOLOGY | 6596 | 3% | 1% | 55 |
6 | JOURNAL OF EXPERIMENTAL MEDICINE | 3860 | 3% | 0% | 50 |
7 | IMMUNOGENETICS | 3117 | 2% | 1% | 27 |
8 | IMMUNOLOGY TODAY | 1831 | 1% | 1% | 13 |
9 | IMMUNOLOGY LETTERS | 1796 | 1% | 0% | 23 |
10 | SCANDINAVIAN JOURNAL OF IMMUNOLOGY | 1780 | 1% | 0% | 23 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CD45 | 720224 | 9% | 27% | 139 | Search CD45 | Search CD45 |
2 | CD45 ISOFORMS | 309030 | 2% | 59% | 27 | Search CD45+ISOFORMS | Search CD45+ISOFORMS |
3 | P56LCK | 212325 | 2% | 33% | 33 | Search P56LCK | Search P56LCK |
4 | LCK INHIBITOR | 181508 | 1% | 85% | 11 | Search LCK+INHIBITOR | Search LCK+INHIBITOR |
5 | LCK | 177014 | 3% | 20% | 45 | Search LCK | Search LCK |
6 | PTPRC | 60938 | 0% | 63% | 5 | Search PTPRC | Search PTPRC |
7 | LPAP | 58504 | 0% | 100% | 3 | Search LPAP | Search LPAP |
8 | P50CSK | 58504 | 0% | 100% | 3 | Search P50CSK | Search P50CSK |
9 | PYRIMIDINE BENZIMIDAZOLES | 58504 | 0% | 100% | 3 | Search PYRIMIDINE+BENZIMIDAZOLES | Search PYRIMIDINE+BENZIMIDAZOLES |
10 | P59FYN | 49912 | 0% | 32% | 8 | Search P59FYN | Search P59FYN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |